| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 598,282 | 755,875 | 869,190 | 1,067,263 | | Cost of Revenue | 484,987 | 579,018 | 627,260 | 784,689 | | | Gross Profit | 113,295 | 176,857 | 241,930 | 282,574 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 203,434 | 217,955 | 209,473 | 239,752 | | Non Recurring | 2,341 | 325,445 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (92,480) | (366,543) | 32,457 | 42,822 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,575) | 718 | (894) | (1,924) | | Earnings Before Interest And Taxes | (94,055) | (365,825) | 31,563 | 40,898 | | Interest Expense | 728 |
-
|
-
| 2,700 | | Income Before Tax | (94,783) | (365,825) | 31,563 | 38,198 | | Income Tax Expense | (28,224) | (48,951) | 8,351 | 6,139 | | Minority Interest |
-
|
-
| 34 | (333) | | | | Net Income From Continuing Ops | (66,559) | (316,874) | 23,246 | 31,726 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (66,559) | (316,874) | 23,246 | 31,726 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($66,559) | ($316,874) | $23,246 | $31,726 |
|
0.45% Nasdaq 
0.20%
Income Statement
